Integra LifeSciences appoints new SeaSpine chief executive officer and chief financial officer

1165

Integra LifeSciences Holdings Corporation has announced the appointment of Keith Valentine as chief executive officer of SeaSpine Holdings Corporation, which will be an independent, publicly traded company following the completion of its spin-off from Integra. SeaSpine has a portfolio of orthobiologics and spinal fusion hardware solutions.

“With more than 20 years of experience in the orthopaedic industry and an outstanding track record of success, Keith’s proven leadership skills will drive growth and innovation at SeaSpine,” said Peter Arduini, Integra’s president and chief executive officer.

Prior to joining SeaSpine, Valentine served as president and chief operating officer of NuVasive. “SeaSpine has the ability to leverage its leading orthobiologics products and broad spinal fusion hardware portfolio, as well as invest in a pipeline of differentiated products to drive growth. I look forward to working with our customers, our strong management team, employees, and our future investors in the coming weeks and months,” said Valentine.

John Bostjancic was also recently named chief financial officer of SeaSpine. Bostjancic has been the acting chief financial officer of SeaSpine since December 2014. He was most recently a senior vice president of global supply chain at Integra.

Kirt Stephenson, future chairman of SeaSpine’s board of directors, said, “We are pleased to have a chief executive officer with Keith’s background and track record, as well as a proven financial executive in John Bostjancic. We now have the leadership team in place to lead an independent SeaSpine forward.”